Skip to content

EBITDA at other companies

Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$14.44M+0.2%
Alphatec Holdings logo
Alphatec HoldingsATEC
-$3.45M+85.9%
SI-BONE, Inc. logo
SI-BONE, Inc.SIBN
-$3.48M+44.0%
Johnson & Johnson logo
Johnson & JohnsonJNJ
Stryker logo
StrykerSYK
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH

Other financials

Income statement

See full
Revenue$20.9M-36.5%
Gross profit$12.0M-40.9%
Operating income-$2.9M-375%
Net income-$3.1M-5,426%
EPS (diluted)-$0.02

Balance sheet

See full
Cash & equivalents$12.2M+124%
Total debt$15.0M-34.9%
Total equity$48.6M+10.8%
Total assets$78.0M-18.6%

Cash flow

See full
Operating cash flow-$2.1M-265%
CapEx$194.0K-83.7%
Free cash flow-$2.3M-2,753%

Valuation

See full
Market cap$59.05M-32.5%
Enterprise value$61.89M-41.5%
P/E32.3×
P/S0.5×-0.2×

Profitability

See full
Gross margin62.3%+4.2pp
Operating margin4.8%+2.8pp
Net margin1.5%+0.8pp
FCF margin6.4%+4.1pp

Returns & leverage

See full
Return on equity3.9%+2.1pp
Debt / equity0.3×-0.2×
Current ratio3.3×+1.0×

Where this comes from

Calculated from Xtant Medical Holdings’s reported figures.

$2.9Mebit+
$534.0KDepreciation Depletion & Amortization
=-$2.39M

The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xtant Medical Holdings's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xtant Medical Holdings's EBITDA?
Xtant Medical Holdings (XTNT) reported EBITDA of -$2.39M in Q1 2026.
How has Xtant Medical Holdings's EBITDA changed year-over-year?
Xtant Medical Holdings's EBITDA decreased by 211.8% year-over-year, from $2.14M to -$2.39M.
What is the long-term trend for Xtant Medical Holdings's EBITDA?
Over 4 years (2021 to 2025), Xtant Medical Holdings's EBITDA has grown at a 58.2% compound annual growth rate (CAGR), from -$2.52M to $15.77M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.